pH-Responsive supramolecular prodrug micelles based on cucurbit[8]uril for intracellular drug delivery.

Yin Wang,Dan-dan Li,Qiao Jin,J. Ji

DOI: https://doi.org/10.1016/j.jconrel.2015.05.227

IF: 11.467

2015-09-10

Journal of Controlled Release

Abstract:

What problem does this paper attempt to address?

Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients

DOI: https://doi.org/10.2147/jmdh.s453429

2024-03-14

Journal of Multidisciplinary Healthcare

Abstract:Qing-Yu Xiao, 1 Ren-Ling Wang, 2 Hai-Jun Wu, 1 Wen-Bin Kuang, 3 Wei-Wei Meng, 4 Zhen Cheng 5 1 Department of Blood Transfusion, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, 518108, China; 2 Department of Oncology, Kaiping Central Hospital, Jiangmen City, Guangdong Province, 529399, People's Republic of China; 3 Department of Laboratory, Longhua District Central Hospital, Shenzhen, 518110, People's Republic of China; 4 Department of Laboratory, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, 518108, China; 5 Guantian Community Healthcare Center, Shenzhen Baoan Shiyan People's Hospital, Shenzhen, Guangdong province, 518100, People's Republic of China Correspondence: Zhen Cheng, Guantian Community Healthcare Center, Shenzhen Baoan Shiyan People's Hospital, About 50 Meters South of hkc Huike Industrial Park, Dezheng Road, Baoan District, Shenzhen, Guangdong province, 518100, People's Republic of China, Tel +86 13632854050, Email Objective: To probe into the influence of Helicobacter pylori (Hp) infection on glucose metabolism, lipid metabolism, and inflammatory cytokines in patients with nonalcoholic fatty liver disease (MASLD). Methods: A total of 140 MASLD patients admitted to our Hospital between June 2020 and May 2021 were selected as the research objects. Based on the presence or absence of Hp infection, they were divided into the study group (73 cases with infection) and control group (67 cases without infection). Glucose metabolism indicators [fasting blood glucose (FBG), 2-hour postprandial glucose (2hPG), fasting insulin (FINS), glycated hemoglobin (HbAlc)], lipid metabolism indicators [total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C)], and inflammatory indicators [interleukin-37 (IL-37), interleukin-18 (IL-18)] were measured and compared between the two groups. Results: In terms of glucose metabolism indicators, the study group exhibited higher levels of FBG (5.84± 0.49 vs 5.40± 0.51, t =2.535, P =0.012), 2hPG (7.26± 1.30 vs 6.50± 1.53, t =3.321, P < 0.001), and FINS (11.13± 4.13 vs 9.12± 3.72, t =3.224, P < 0.001), and Insulin resistance index (HOMA-IR) (2.97± 0.35 VS 2.13± 0.54, t =3.761, P < 0.001) and a lower level of HbAlc (5.25± 0.56 vs 6.12± 0.57, t =5.473, P < 0.001) compared to the control group. Regarding lipid metabolism indicators, the study group exhibited higher levels of TC (5.64± 1.49 vs 5.01± 1.32, t =3.332, P < 0.001), TG (1.89± 0.34 vs 1.32± 0.43, t =3.411, P < 0.001), and LDL-C (3.31± 0.43 vs 2.12± 0.29, t =4.142, P < 0.001), and a lower level of HDL-C (1.45± 0.21 vs 1.78± 0.42, t =4.347, P < 0.001) compared to the control group. As for the inflammatory indicators, the study group exhibited higher levels of IL-37 (45.56± 6.02 vs 34.02± 3.28, t =9.332, P < 0.001) and IL-18 (73.57± 5.82 vs 60.34± 4.84, t =10.141, P < 0.001) compared to the control group. Conclusion: It is crucial to place appropriate emphasis on the impact of Hp infection on the glucose metabolism, lipid metabolism, and inflammatory response in MASLD patients, warranting careful consideration during the treatment of these patients. Keywords: Helicobacter pylori, infection, nonalcoholic fatty liver disease, glucose metabolism, lipid metabolism, inflammatory indicators Nonalcoholic fatty liver disease (MASLD) refers to hepatic disorders with a lipid content alteration of over 5%, is now recognized as a global public health problem. MASLD affects 20% to 45% of the general population, and prevalence is increasing globally. 1 This condition is mainly caused by obesity, diabetes, hyperlipidemia and other metabolic syndrome or malnutrition, total parenteral nutrition, sharp weight loss after weight loss surgery, drugs / environment and so on. 2 Failure to implement timely preventive and therapeutic measures can result in the progression of MASLD to more severe conditions, including advanced liver fibrosis, cirrhosis, and even the development of malignancies. Nonalcoholic steatohepatitis (NASH) has emerged as the primary cause of chronic liver inflammation. 3–5 MASLD can give rise to a spectrum of clinical pathological syndromes. 6–8 The etiology of MASLD involves insulin resistance (IR) and genetic defects, which profoundly impact the normal physiological functioning of the body and may have negative effects on the patients' quality of life. In recent years, extensive research has identified the -Abstract Truncated-

health care sciences & services
Response to Article "Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients"

Putu Yuliandari,I Putu Bayu Mayura

DOI: https://doi.org/10.2147/jmdh.s469382

2024-03-28

Journal of Multidisciplinary Healthcare

Abstract:Putu Yuliandari, 1 I Putu Bayu Mayura 2 1 Centre for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Bogor, West Java, Indonesia; 2 Department of Microbiology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia Correspondence: Putu Yuliandari, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Jl. Raya Jakarta - Bogor Km. 46, Cibinong, Bogor, West Java, Indonesia, Email View the original paper by Dr Xiao and colleagues We have read the article by Xiao et al about "Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients". 1 This study investigates the impact of Helicobacter pylori infection on glucose metabolism, lipid metabolism, and inflammatory cytokines in patients with nonalcoholic fatty liver disease (MASLD). Nonalcoholic fatty liver disease, now known as metabolic-dysfunction-associated steatotic liver disease (MASLD), is a leading cause of chronic liver disease worldwide. The global prevalence of MASLD has been increasing over time, with a recent meta-analysis estimating that MASLD afflicts 32% of the adult population. 2 Since the initial report of H. pylori DNA being detected in the liver of non alcoholic fatty liver disease patients, numerous studies have investigated the relationship between H. pylori infection and this disease. 3 The authors have utilized diagnostic criteria from the "Prevention and Treatment Guidelines for Nonalcoholic Fatty Liver Disease" which may not be readily accessible to an international audience due to the language barrier. The retrospective nature of the study implies reliance on diagnostic standards that have since been updated, as noted in the June 2023 revision by Rinella et al. 4 The study's methodology, particularly the use of the 14C-urea breath test to diagnose H. pylori infection, has inherent limitations. Future investigations could enhance diagnostic accuracy through molecular techniques, such as PCR, to detect H. pylori and its virulence factors, including variations in the cytotoxin-associated gene A (Cag A) status. 3 There is a direct association between H. pylori infection and insulin resistance and dyslipidemia, both presently recognized as factors contributing to the development of MASLD. Several studies revealed a positive correlation between H. pylori infection and MASLD, similar to this study, while some clinical studies negate this conclusion. 3 This may be due to variability in H. pylori strains, inconsistent H. pylori diagnostic methods, updated MASLD diagnostic criteria, and regional differences in race, genetics, lifestyle, and dietary habits. A possible mechanism of interaction between H. pylori infection and MASLD involves fetuin-A or alpha 2-HS glycoprotein (AHSG). Higher serum fetuin-A levels in H. pylori-positive patients have been reported to correlate with impaired insulin sensitivity and glucose tolerance. 5 Fetuin-A also acts as an endogenous adaptor protein for free fatty acid-mediated activation of TLR4 in mice. This might reflect the presence of a broad panel of inflammatory mediators (c-reactive protein, TNF-α, IL-6, IL-1β) in patients suffering from H. pylori infection. 6 Future research should employ large-scale and multi-center randomized controlled trials to objectively and effectively assess the influence of H. pylori infection in MASLD patients. We acknowledge and appreciate this study's contribution to the field of hepatology and gastroenterology, highlighting the extragastric influence of H. pylori on metabolic diseases. It lays a foundation for future research to explore the relationships between H. pylori infection, metabolic dysregulation, and MASLD more deeply, potentially leading to improved patient outcomes. The authors would like to acknowledge all the researchers and Prof. Dr. Sunarno in the Center for Biomedical Research BRIN for their continuous support. The authors would also like to convey gratitude to the research team of Xiao et al for their valuable research report. The authors have disclosed no conflicts of interest in this communication. 1. Xiao Q, Wang R, Wu H, Kuang W, Meng W, Cheng Z. Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients. J Multidisciplinary Healthcare . 2024;17:1127–1135. doi:10.2147/JMDH.S453429 2. Teng MLP, Ng CH, Huang DQ, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol . 2023;29(supp1):32–42. doi:10.3350/CMH.2022.036 -Abstract Truncated-

health care sciences & services
Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.

Longui Ning,Rongqiang Liu,Xinhe Lou,Haojie Du,Wenguo Chen,Fenming Zhang,Sha Li,Xueyang Chen,Guoqiang Xu

DOI: https://doi.org/10.1097/MEG.0000000000001398

2019-01-01

European Journal of Gastroenterology & Hepatology

Abstract:Although clinical studies have shown possible links of Helicobacter pylori infection with the development of nonalcoholic fatty liver disease (SNAFLD), the results remain controversial. The aim of this meta-analysis is to investigate the association between H. pylori infection and NAFLD. A comprehensive search of relevant studies was performed up to November 2018. Data on H. pylori infection in NAFLD patients and controls were extracted. Odds ratio (OR) and 95% confidence interval (CI) were calculated using a random-effects model. Twelve studies involving 27 400 NAFLD patients and 60 347 controls were included. The pooled overall OR of H. pylori infection in NAFLD patients compared with controls was 1.36 (95% CI: 1.22-1.53, I-2=89.6%, P=0.000). Met-aregression and subgroup analysis showed that the sample size and the case-control ratio may have accounted for some of the heterogeneity. When stratified by publication year, the diagnostic method used for H. pylori, and Newcastle-Ottawa Scale scores, the OR remained significant. However, possible publication bias was observed. Of the 12 studies, six had carried out multivariable analysis after adjusting for potential confounders. The pooled results from these studies still indicated a higher risk of NAFLD in patients infected with H. pylori (OR=1.17, 95% CI: 1.01-1.36, I-2=72.4%, P=0.003). There is a 36% increased risk of NAFLD in patients with H. pylori infection. Further studies are warranted to investigate whether eradication of H. pylori is useful in the prevention and treatment of NAFLD.
Correlation Between Colon Polyps and Metabolic Syndrome and HP Infection Status

Lijuan Huang,Lihong Wu,Qiaohua Qiao,Lizheng Fang

DOI: https://doi.org/10.1155/2019/3916154

IF: 2

2019-01-01

Gastroenterology Research and Practice

Abstract:Background This study investigated the relationships among the characteristics of colon polyps and potential risk factors, including metabolic condition, CEA level, uric acid level, and Helicobacter pylori (Hp) infection status. Method Clinical data from patients who received colonoscopy were collected and analyzed, including patients' gender, age, polyp pathology, metabolic syndrome (MS) status, CEA level, uric acid level, and Hp infection status. Patients were divided into a polyp group and a control group based on whether they presented with colon polyps. Then, clinical data were compared between the two groups to identify any differences between the groups and their relationships to colon polyps. Result Compared with the control group, the polyp group had significant differences in patient gender, body mass index (BMI), waistline, blood pressure, fasting blood glucose level, blood lipid level, and uric acid level (p < 0.05), but there were no significant differences in LDL and CEA levels (p > 0.05). Patients with MS or a uric acid level > 340 mg/dl had a greater tendency to develop colon polyps but this was not statistically significant. Conclusion The incidence of colon polyps may be associated with MS and uric acid levels, but further studies are warranted to confirm this conclusion.
Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study

Xingcen Chen,Ruyi Peng,Dongzi Peng,Deliang Liu,Rong Li

DOI: https://doi.org/10.1186/s12967-024-05506-y

2024-07-29

Abstract:Background: The relationship between Helicobacter pylori (H. pylori) infection and metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted increased clinical attention. However, most of those current studies involve cross-sectional studies and meta-analyses, and experimental mechanistic exploration still needs to be improved. This study aimed to investigate the mechanisms by which H. pylori impacts MASLD. Methods: We established two H. pylori-infected (Cag A positive and Cag A negative) mouse models with 16 weeks of chow diet (CD) or high-fat diet (HFD) feeding. Body weight, liver triglyceride, blood glucose, serum biochemical parameters, inflammatory factors, and insulin resistance were measured, and histological analysis of liver tissues was performed. Mouse livers were subjected to transcriptome RNA sequencing analysis. Results: Although H. pylori infection could not significantly affect serum inflammatory factor levels and serum biochemical parameters in mice, serum insulin and homeostatic model assessment for insulin resistance levels increased in CD mode. In contrast, H. pylori Cag A + infection significantly aggravated hepatic pathological steatosis induced by HFD and elevated serum inflammatory factors and lipid metabolism parameters. Hepatic transcriptomic analysis in the CD groups revealed 767 differentially expressed genes (DEGs) in the H. pylori Cag A + infected group and 1473 DEGs in the H. pylori Cag A- infected group, and the "nonalcoholic fatty liver disease" pathway was significantly enriched in KEGG analysis. There were 578 DEGs in H. pylori Cag A + infection combined with the HFD feeding group and 820 DEGs in the H. pylori Cag A- infected group. DEGs in the HFD groups were significantly enriched in "fatty acid degradation" and "PPAR pathway." Exploring the effect of different Cag A statuses on mouse liver revealed that fatty acid binding protein 5 was differentially expressed in Cag A- H. pylori. DEG enrichment pathways were concentrated in the "PPAR pathway" and "fatty acid degradation." Conclusions: Clinicians are expected to comprehend the impact of H. pylori on MASLD and better understand and manage MASLD. H. pylori infection may exacerbate the development of MASLD by regulating hepatic lipid metabolism, and the H. pylori virulence factor Cag A plays a vital role in this regulation.
Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease

Mohamed Rakha,Omayma Saleh,Mohamed S. Abdelgawad,Azza El Baiomy

DOI: https://doi.org/10.1186/s43066-020-00071-7

2021-01-22

Egyptian Liver Journal

Abstract:Abstract Background Helicobacter pylori (HP) infection is considered a risk factor of GIT diseases, e.g., gastric and duodenal ulcers and gastric carcinomas. It is transmitted through feco/oral route and can be diagnosed by many methods, e.g., stool antigen test (SAT). Metabolic syndrome (MET S) is considered a circle of metabolic derangements that can cause some complications as ischemic changes and heart diseases. Metabolic syndrome may also cause nonalcoholic fatty liver disease (NAFLD) resulting in liver fibrosis, cirrhosis, and HCC. Results The study included 300 subjects recruited from Obesity Clinic and Diabetes & Endocrinology Unit, Specialized Medical Hospital, Mansoura University. Two hundred of metabolic syndrome patients were subdivided into two groups according to the presence or absence of NAFLD, in addition to 100 subjects not having metabolic syndrome and served as control group. We found that HP infection is more frequent in MET S with NAFLD patients (73%) than in MET S without NAFLD (47%) with ( P value < 0.001) emphasizing that HP infection increases the risk of NAFLD development in patients with MET S. The study proved that HP infection is associated with increased degree of fibrosis significantly ( P value < 0.001) with progression to marked fibrosis which may complicate with NASH with over all predictive value of 75% especially in patients with hyperglycemia. Conclusions Our findings show that a circle of metabolic abnormalities seems to be attributed to HP infection in MET S patients increasing the risk of fatty liver and progression to marked fibrosis especially with coexistent hyperglycemia, dyslipidemia, and upper body obesity. Diagnosis and early eradication of HP infection will help in decreasing metabolic disturbances and possibility of NAFLD, and protect against marked fibrosis progression.
IsHelicobacter Pyloriinfection Associated with Glycemic Control in Diabetics?

Yi-Ning Dai,Wei-Lai Yu,Hua-Tuo Zhu,Jie-Xia Ding,Chao-Hui Yu,You-Ming Li

DOI: https://doi.org/10.3748/wjg.v21.i17.5407

2015-01-01

Abstract:AIM:To investigate whether Helicobacter pylori (H. pylori) infection is associated with glycemic control and whether hyperglycemia is modified by eradication therapy.METHODS:The databases of PubMed, Cochrane Library, Chinese BioMedicine Web Base and Chinese Science and Technology Journals were searched from inception to June 2014. Studies examining the association between H. pylori infection and glycemic control and/or the effect of eradication treatment on glycemic control in diabetic humans were eligible for inclusion. Meta-analyses were conducted using the Review Manager software version 5.2. The outcome measures are presented as weighed mean differences (WMDs) with 95% confidence intervals (CIs). Statistical heterogeneity was assessed by the Cochran Q test and the I(2) statistic.RESULTS:A total of 21 relevant publications were identified. A meta-analysis of 11 studies with 513 patients with diabetes mellitus (DM) showed significantly lower glycosylated hemoglobin (HbA1c) levels in the H. pylori-negative than H. pylori-positive DM participants (WMD = 0.43, 95%CI: 0.07-0.79; P = 0.02). In children and adolescents with type 1 DM (T1DM), there was a positive association between H. pylori infection and HbA1c level (WMD = 0.35, 95%CI: 0.05-0.64; P = 0.02), but there was no difference in those with type 2 DM (T2DM, WMD = 0.51, 95%CI: -0.63-1.65; P = 0.38). A meta-analysis of six studies with 325 T2DM participants showed a significant difference in the fasting plasma glucose levels between H. pylori-positive and H. pylori-negative participants (WMD = 1.20, 95%CI: 0.17-2.23; P = 0.02). Eradication of H. pylori did not improve glycemic control in the T2DM participants in a three-month follow-up period (HbA1c decrease: WMD = -0.03, 95%CI = -0.14-0.08; P = 0.57; fasting plasma glucose decrease: WMD = -0.06, 95%CI: -0.36-0.23; P = 0.68). Glycemic control was significantly better in T1DM participants who were not reinfected than in those who were reinfected (HbA1c: WMD = 0.72, 95%CI: 0.32-1.13: P = 0.00).CONCLUSION:H. pylori infection is associated with poorer glycemic control in T1DM patients, but eradication may not improve glycemic control in DM in a short-term follow-up period.
The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease

Facundo Maiorana,Magali Neschuk,María Virginia Caronia,Karina Elizondo,María Laura Robledo,Adolfo Schneider,Georgina Veron,Pedro Dario Zapata,Fernando Javier Barreyro

DOI: https://doi.org/10.1371/journal.pone.0310361

IF: 3.7

2024-09-23

PLoS ONE

Abstract:Background: Recent studies have suggested an association between H. pylori and metabolic-disfunction associated fatty liver disease (MASLD). However, epidemiologic studies have yielded inconsistent results. We aim to evaluate the association of H. pylori and G-allele PNPLA3 in MASLD diagnosis, and markers of severity. Methods: A multi-center cross-sectional study was conducted. A total 224 functional dyspepsia (FD) patients cohort who underwent gastroscopy was selected. Biochemical, clinical parameters, ultrasound, FIB-4 score, LSM by VCTE, gastric biopsies, H. pylori status, and rs738409 PNPLA3 were evaluated. A second retrospective cohort of 86 patients with biopsy-proven MASLD who underwent gastroscopy with gastric biopsies was analyzed. Results: In the FD cohort MASLD was observed in 52%, and H. pylori-positive in 51%. H. pylori infection was associated with MASLD prevalence, but in multivariate analyses adjusted for G-allele PNPLA3, it became not significant. Then in MASLD-only dyspeptic cohort, H. pylori infection was significantly linked to elevated serum AST levels and increased liver stiffness measurements, suggesting a potential role in liver injury and fibrosis. Histopathological analysis in biopsy-proven MASLD patients further supported these findings, showing a significant association between H. pylori infection and increased NAS score, fibrosis stage, and prevalence of MASH. Notably, the combination of H. pylori infection and G-allele PNPLA3 appeared to exacerbate MASLD severity beyond individual effects. Conclusions: Our results suggest that H. pylori infection may play a role in the progression of liver injury and fibrosis in patients with MASLD, especially in those with specific genetic predispositions.
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis

Alessandro Mantovani,Maria Giovanna Lando,Nicolò Borella,Enrico Scoccia,Barbara Pecoraro,Federico Gobbi,Zeno Bisoffi,Luca Valenti,Herbert Tilg,Christopher D. Byrne,Giovanni Targher

DOI: https://doi.org/10.1111/liv.15925

IF: 8.754

2024-04-05

Liver International

Abstract:Background Recent observational studies examining the association between Helicobacter pylori infection and the risk of metabolic dysfunction‐associated steatotic liver disease (MASLD) have reported conflicting results. We performed a meta‐analysis to quantify the magnitude of the association between H. pylori infection and the risk of MASLD. Methods We systematically searched three large electronic databases to identify eligible observational studies (published up to 30 November 2023) in which liver biopsy, imaging methods or blood‐based biomarkers/scores were used for diagnosing MASLD. Data from selected studies were extracted, and meta‐analysis was performed using common and random‐effects modelling. Statistical heterogeneity among published studies, subgroup analyses, meta‐regression analyses and publication bias were assessed. Results A total of 28 observational studies (24 cross‐sectional and 4 longitudinal studies) were identified, including 231 291 middle‐aged individuals of predominantly Asian ethnicity (~95%). Meta‐analysis of cross‐sectional studies showed that H. pylori infection was significantly associated with a small increase in the risk of prevalent MASLD (n = 24 studies; random‐effects odds ratio 1.11, 95% CI 1.05–1.18; I2 = 63%). Meta‐analysis of data from longitudinal studies showed that H. pylori infection was significantly associated with an increased risk of developing incident MASLD over a mean 5‐year follow‐up (n = 4 studies; random‐effects odds ratio 1.20, 95%CI 1.08–1.33; I2 = 44%). Sensitivity analyses did not modify these results. The funnel plot did not reveal any significant publication bias. Conclusions H. pylori infection is associated with a mildly increased risk of prevalent and incident MASLD. Further well‐designed prospective and mechanistic studies are required to better decipher the complex link between H. pylori infection and the risk of MASLD.

gastroenterology & hepatology
Three‐dimensional dynamic bone histomorphometry

Craig R. Slyfield,E. V. Tkachenko,D. Wilson,C. Hernandez

DOI: https://doi.org/10.1002/jbmr.553

IF: 6.39

2012-02-01

Journal of Bone and Mineral Research

Abstract:Dynamic bone histomorphometry is the standard method for measuring bone remodeling at the level of individual events. Although dynamic bone histomorphometry is an invaluable tool for understanding osteoporosis and other metabolic bone diseases, the technique's two‐dimensional nature requires the use of stereology and prevents measures of individual remodeling event number and size. Here, we used a novel three‐dimensional fluorescence imaging technique to achieve measures of individual resorption cavities and formation events. We performed this three‐dimensional histomorphometry approach using a common model of postmenopausal osteoporosis, the ovariectomized rat. The three‐dimensional images demonstrated the spatial relationship between resorption cavities and formation events consistent with the hemiosteonal model of cancellous bone remodeling. Established ovariectomy was associated with significant increases in the number of resorption cavities per unit bone surface (2.38 ± 0.24 mm−2 sham surgery versus 3.86 ± 0.35 mm−2 bilateral ovariectomy [OVX], mean ± SD, p < 0.05) and total volume occupied by cavities per unit bone volume (0.38% ± 0.06% sham versus 1.12% ± 0.18% OVX, p < 0.001), but there was no difference in surface area per resorption cavity, maximum cavity depth, or cavity volume. In addition, we found that established ovariectomy is associated with increased size of bone formation events because of the merging of formation events (23,700 ± 6,890 µm2 sham verusus 33,300 ± 7,950 µm2 OVX). No differences in mineral apposition rate (determined in 3D) were associated with established ovariectomy. That established estrogen depletion is associated with increased number of remodeling events with only subtle changes in remodeling event size suggests that circulating estrogens may have their primary effect on the origination of new basic multicellular units with relatively little effect on the progression and termination of active remodeling events. © 2012 American Society for Bone and Mineral Research
The Associations among Helicobacter Pylori Infection, White Blood Cell Count and Nonalcoholic Fatty Liver Disease in a Large Chinese Population

Ying-ying Yu,Jian-ting Cai,Zhen-ya Song,Yu-ling Tong,Jing-hua Wang

DOI: https://doi.org/10.1097/md.0000000000013271

IF: 1.6

2018-01-01

Medicine

Abstract:Abstract Reported relationships among Helicobacter pylori infection, white blood cell (WBC) count and nonalcoholic fatty liver disease (NAFLD) are inconsistent and controversial. We, therefore, conducted a cross-sectional study to investigate the associations among the presence of NAFLD, WBC count and H pylori infection, as diagnosed using the 13C-urea breath test (UBT). This study included 20,389 subjects enrolled at the International Health Care Center of the Second Affiliated Hospital of the Zhejiang University School of Medicine from January 2015 to December 2015. All participants underwent a 13C-UBT for the diagnosis of H pylori infection and ultrasonography for NAFLD as well as a blood test to determine WBC count. Multivariate logistic regression was then performed to evaluate the relationship among H pylori infection, WBC count and NAFLD. H pylori infection was detected in 38.49% (7,848/20,389) of the subjects via the UBT, and NAFLD was present in 37.24% (7,592/20,389) of the subjects. The prevalence of H pylori infection was higher in the NAFLD group than in the control group (41.25% vs 36.85%, P <.001). Significant differences were found between various WBC quartiles and H pylori infection, age, gender, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), high-sensitivity C-reactive protein (HS-CRP), glycosylated hemoglobin (HbA1c), triglyceride (TG), low-density lipoprotein (LDL-C), fasting blood glucose (FPG), homeostasis model assessment of insulin resistance (HOMA-IR), and smoking. Multivariate logistic regression revealed that the combination of H pylori infection and WBC count (odds ratio [OR] = 1.067, 95% confidence interval [CI]: 1.014, 1.093; P = .007; OR = 1.165, 95% CI: 1.023, 1.488; P <.001; OR = 1.183, 95% CI: 1.085, 1.559; P <.001, respectively) was positively associated with NAFLD. H pylori infection and WBC count may contribute to the pathogenesis of NAFLD.
Median and Ulnar 14-cm Antidromic Sensory Studies to the Third and Fifth Digits-A Comparison of Amplitude.

R. Buschbacher,Andrew Berkson,Douglas Mottley,Z. Omar

DOI: https://doi.org/10.1615/JLONGTERMEFFMEDIMPLANTS.V16.I5.100

Journal of Long-Term Effects of Medical Implants

Abstract:There are multiple reports of peripheral nerve injury following the implantation or removal of surgical hardware. Electrodiagnostic testing can be useful in assessing the chronicity, severity, and recovery of such a nerve injury. The purpose of this study is to establish a normative data set to allow for comparison of median and ulnar antidromic sensory peak-to-peak amplitude values. Median and ulnar antidromic sensory studies to digits 3 and 5 are commonly performed in electrodiagnosis to aid in the diagnosis of a variety of clinical conditions. Numerous studies have examined normal latency and amplitude values for these studies. To our knowledge there has been one other study that compared the relationship between median and ulnar sensory amplitude results taken from the same limb. That study had limited generalizability to the population at large. One hundred-nineteen volunteers were tested with antidromic sensory technique to digits 3 and 5 at 14-cm stimulation distance. Peak latency and peak-to-peak amplitude were recorded. Possible relationships between age, gender, height, weight, BMI, and median and ulnar amplitude were examined through simple linear regressions. Age, weight, height, and BMI were all found to negatively correlate with both median and ulnar amplitude. Female subjects were found to have statistically greater median and ulnar amplitudes than male subjects. Factors were said to be statistically significant at the P </= 0.05 level. The mean median peak latency was 3.2 +/- 0.3 ms. The mean ulnar peak latency was 3.2 +/- 0.4 ms. The mean median peak-to-peak amplitude was 87 +/- 36 muV. The mean ulnar peak-to-peak amplitude was 72 +/- 34 muV. The upper limit of normal difference (2.5th percentile) in median-versus-ulnar amplitude was a 56% drop from median-to-ulnar amplitude, or a 59% drop from ulnar-to-median amplitude. This allows for amplitude comparisons to be made between these two nerves.
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease

Facundo Maiorana,Magali Neschuk,María Virginia Caronia,Karina Elizondo,Adolfo Schneider,Georgina Veron,Pedro D Zapata,Fernando Javier Barreyro

DOI: https://doi.org/10.1016/j.aohep.2024.101541

2024-08-29

Abstract:Introduction and objectives: Recent studies have suggested an association between H. pylori and metabolic dysfunction associated steatotic liver disease (MASLD). We aim to evaluate the association of H. pylori virulence genes with non-invasive markers of liver injury and fibrosis in MASLD subjects. Patients and methods: A total of 362 dyspeptic patients who underwent gastroscopy were selected. Biochemical, clinical parameters, ultrasound, FIB-4 score, liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE), gastric biopsies, and H. pylori virulence genes (cagA, vacA) were evaluated. Results: A cohort comprised of 61 % women and 39 % men with a median age of 52 (40-60) years. MASLD was observed in 42 %, and H. pylori-positive in 45 %. No differences were observed regarding H. pylori status at co-morbid metabolic conditions. In MASLD cohort, H. pylori-positive was associated with higher AST, ALT, FIB-4 and LSM. Indeed, carriers of cagA/vacA-s1/m1-positive allelic combination were associated with higher AST, ALT, FIB-4 and LSM but not cagA/vacA-s1/m1-negative. The OR for high-risk of significant/advanced- fibrosis by VCTE (≥8 kPa) with H. pylori-positive was 2.56 (95 % CI, 1.2-5.75) and for cagA/vacA-s1/-m1-positive allelic carriers was 4.01 (95 % CI, 1.38-11.56), but non-significant association in cagA/vacA-s1/-m1-negative. After adjusting for age, gender, diabetes, BMI and hypertension the OR for VCTE ≥8 kPa with H. pylori-positive was 2.43 (95 % CI, 1.88-12.44), and cagA/vacA-s1/m1-positive allelic carriers was 4.06 (95 % CI, 1.22-14.49). Conclusions: In our cohort of FD patients with MASLD, H. pylori was associated with non-invasive markers of liver injury and fibrosis. Carriers of cagA/vacA-s1/m1-positive allelic combination showed an independent risk of significant/advanced fibrosis by VCTE.
Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial

Ying-ying Yu,Yu-ling Tong,Ling-yan Wu,Xin-yan Yu

DOI: https://doi.org/10.1038/s41598-022-23746-0

IF: 4.6

2022-11-16

Scientific Reports

Abstract:Previous studies have suggested that Helicobacter pylori ( H. pylori ) infection is associated with nonalcoholic fatty liver disease (NAFLD). The purpose of the present study was to investigate the effect of H. pylori eradication treatment on NAFLD patients. Two hundred NAFLD patients who tested positive for H. pylori infection were randomized into the H. pylori eradication treatment group or the control group. Metabolic and inflammatory parameters and FibroScan were measured in all subjects at baseline and 1 year after treatment. At 1 year after treatment, the decrease in metabolic indicators, such as fasting blood glucose, glycosylated haemoglobin, homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides, body mass index and controlled attenuation parameter values, were more obvious in the treatment group. Moreover, the inflammatory indicators white blood count and high-sensitivity C-reactive protein (hs-CRP) and the inflammatory factors interleukin 6 (IL-6) and tumour necrosis factor-α (TNF-α) were also significantly decreased. H. pylori eradication can further reduce the metabolic indices of NAFLD and the degree of liver steatosis. H. pylori infection may participate in the occurrence and development of NAFLD through its influence on inflammatory factors. Thus, checking for the presence of H. pylori infection in patients at risk of NAFLD may be beneficial.

multidisciplinary sciences
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome

Chen Chen,Caiyun Zhang,Xuelin Wang,Feijuan Zhang,Ze Zhang,Pengchai Ma,Shuzhi Feng

DOI: https://doi.org/10.1097/meg.0000000000001601

2019-11-07

Abstract:Recent clinical trials have confirmed that Helicobacter pylori infection is positively associated with nonalcoholic fatty liver disease (NAFLD), although some research has shown a negative association. Therefore, to confirm whether H. pylori eradication treatment is feasible for NAFLD patients in our hospital, we aimed to establish the association between H. pylori infection and NAFLD.

gastroenterology & hepatology
Association between Helicobacter pylori infection, MASLD, and liver fibrosis in patients with severe obesity: a single-center experience

Abhishek Gulati,Marina Roytman,Joanne Lin,Morgan McGrath,Amarita Klar,Keith Boone,Kelvin Higa,Pearl Ma

DOI: https://doi.org/10.1007/s00464-024-11177-z

2024-08-31

Surgical Endoscopy

Abstract:Our study sought to evaluate if an association exists between Helicobacter pylori (H. pylori), metabolic dysfunction- associated steatotic liver disease (MASLD), and liver fibrosis in patients with severe obesity (BMI > 35). Our retrospective study included 584 patients over the age of 18 years with severe obesity, who underwent preoperative liver transient elastography (VCTE), upper endoscopy, blood work, and intra-operative liver biopsy concurrent with bariatric surgery at a single institution from July 2020 to September 2021. Liver fibrosis scores including FIB-4, APRI, NAFLD fibrosis score, BARD score, AST: ALT ratio, and NAFLD activity score (NAS) were calculated from the laboratory results and liver biopsy findings. The presence or absence of H. pylori was determined based on gastric biopsies obtained during upper endoscopy. Other variables collected included age, gender, mean preoperative weight, BMI, and the presence or absence of comorbidities. Student's t-test and non-parametric testing were used for the analysis of continuous variables and Chi-square analysis was used for categorical data.

surgery
Human keratinocyte locomotion: the effect of selected cytokines.

Y. Sarret,D. Woodley,K. Grigsby,K. Wynn,E. O'Keefe

DOI: https://doi.org/10.1111/1523-1747.EP12493517

IF: 7.59

Journal of Investigative Dermatology

Abstract:Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) are two powerful mitogens for human keratinocytes that also have been shown to promote the healing of in vivo wounds. Transforming growth factor-beta (TGF-beta) markedly inhibits human keratinocyte proliferation and growth and yet has been shown to promote wound healing. Using a migration assay that evaluates pure cell locomotion independently from cell proliferation, we examined the influence of EGF, bFGF, and TGF-B on human keratinocyte locomotion. Although these agents had profound influences upon the growth potential of keratinocytes in parallel thymidine incorporation assays, they had no significant effect upon keratinocyte locomotion when cells were apposed to either tissue culture plastic or a collagen substratum. In contrast, we found that bovine pituitary extract (BPE), a poorly defined mitogen that is commonly used in keratinocyte cultures, could stimulate keratinocyte locomotion when the cells were apposed to a collagen substrate. These studies demonstrate that i) keratinocyte locomotion and proliferation operate by completely independent mechanisms, ii) the positive effects upon wound healing by EGF, bFGF, and TGF-beta are not due to a direct promotion of keratinocyte locomotion, and iii) that one or more components of BPE are capable of directly promoting keratinocyte locomotion on collagen.
[The Effects of Helicobacter Pylori Infection on Hyperammonaemia and Hepatic Encephalopathy in Cirrhotic Patients].

Liang-jing Wang,Jian-ting Cai,Tao Chen,Bin Lü,Jian-min Si

DOI: https://doi.org/10.3760/j.issn:0578-1426.2006.08.013

2006-01-01

Abstract:OBJECTIVE:To evaluate the relationship among Helicobacter pylori (Hp)infection, blood ammonia concentrations, and hepatic encephalopathy (HE) status, and to investigate the effect of Hp eradication on blood ammonia levels and hepatic encephalopathy status in cirrhotic patients.METHODS:From July 2003 to Jan 2005, cirrhotic patients in 5 regions of Zhejiang Province were enrolled. Patients were evaluated for the demographic checklists, number connection test, Hp infection, liver impairment level, blood ammonia concentrations and hepatic encephalopathy status. Patients with Hp infection were given one week therapy with omeprazole plus clarithromycin and tinidazole. (14)C urea breath test was performed and the mental symptoms and blood ammonia levels were reassessed after the eradication therapy.RESULTS:(1) 457 cirrhotics were enrolled, the overall Hp infection rate was 60.6%, and HE happened with 47.5%. Subclinical hepatic encephalopathy (SHE) were detected 55 in 47.0% of 117 cirrhotics. (2) Blood ammonia concentration in Hp (-) and Hp (+) cirrhotics was (53.8 +/- 51.4) micromol/L and (78.4 +/- 63.6) micromol/L respectively (P < 0.01), which was significantly reduced to (53.5 +/- 37.7) micromol/L after Hp eradication (P < 0.01). HE was more frequently observed in patients with Hp infection than without it (58.5% vs 30.6%, P < 0.01). HE rate were significantly dropped to 34.1% after Hp eradication (P < 0.01). (3) Hp prevalence significantly differed among cirrhotic with HE (74.4%), those with SHE (69.1%), or without HE (53.2%) (P < 0.05). The level of blood ammonia had significant difference among the cirrhotics with HE (94.5 +/- 75.6) micromol/L, those with SHE (59.9 +/- 49.2) micromol/L, or without HE (47.3 +/- 33.5) micromol/L (P < 0.05).CONCLUSIONS:Hp infection was an important factor of inducing with high blood ammonia concentration and hepatic encephalopathy in cirrhotic patients. Hp eradication may be helpful for treatment and prevention of HE.
Impedance audiometry as a screening procedure for middle ear disease.

G. McCandless,G. Thomas

Abstract:
Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis

Zeyu Wang,Weijun Wang,Rui Gong,Hailing Yao,Mengke Fan,Junchao Zeng,Sanping Xu,Rong Lin

DOI: https://doi.org/10.1186/s12944-022-01639-5

2022-04-03

Abstract:Background: The impact of Helicobacter pylori (H. pylori) eradication on metabolism of lipid and the potential predictor of such changes remain unclear. Methods: This study retrospectively included subjects who underwent at least two 13C urea breath tests between 2015 and 2019 at Wuhan Union Hospital. Based on two H. pylori 13C examination results, subjects were divided into propensity score-matched persistently negative (HPN), persistently positive (HPP), and eradication (HPE) groups. The changes in lipid measurements from before to after H. pylori eradication, including high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, and triglycerides, were compared within and between groups. Forty-two candidate factors were tested for their ability to predict lipid metabolism changes after H. pylori eradication. Results: After propensity score matching, 3412 matched cases were analyzed. Within-group comparisons showed significantly decreased HDL (P < 0.001) and increased LDL (P < 0.001) at the second examination in both the HPE and HPP groups. Between-group comparisons showed that the HDL decrease of the HPE group was significantly larger and smaller when compared with the HPN (P = 0.001) and HPP (P = 0.004) group, respectively. Uni- and multivariate analyses showed that low diastolic blood pressure (DBP) (P = 0.002) and high mean platelet volume (MPV) (P = 0.001) before eradication were associated with increased HDL after eradication. Low total protein (TP) (P < 0.001) was associated with decreased LDL after eradication. Conclusions: Compared with sustained H. pylori infectious states, H. pylori eradication alleviated the lipid metabolism deterioration but did not restore it to the uninfected level within 1.5 years after eradication. Patients with low DBP, high MPV, and low TP may reap a greater lipid-metabolism benefit from H. pylori eradication.

pH-Responsive supramolecular prodrug micelles based on cucurbit[8]uril for intracellular drug delivery.

Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients

Response to Article "Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients"

Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.

Correlation Between Colon Polyps and Metabolic Syndrome and HP Infection Status

Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study

Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease

IsHelicobacter Pyloriinfection Associated with Glycemic Control in Diabetics?

The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease

Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis

Three‐dimensional dynamic bone histomorphometry

The Associations among Helicobacter Pylori Infection, White Blood Cell Count and Nonalcoholic Fatty Liver Disease in a Large Chinese Population

Median and Ulnar 14-cm Antidromic Sensory Studies to the Third and Fifth Digits-A Comparison of Amplitude.

Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease

Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial

Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome

Association between Helicobacter pylori infection, MASLD, and liver fibrosis in patients with severe obesity: a single-center experience

Human keratinocyte locomotion: the effect of selected cytokines.

[The Effects of Helicobacter Pylori Infection on Hyperammonaemia and Hepatic Encephalopathy in Cirrhotic Patients].

Impedance audiometry as a screening procedure for middle ear disease.

Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis